Enterprise Value

-67.15M

Cash

246.5M

Avg Qtr Burn

-31.48M

Short % of Float

23.24%

Insider Ownership

49.35%

Institutional Own.

35.14%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Posoleucel Details
Human herpesvirus 6, Epstein-Barr virus, Adenovirus, BK virus, Cytomegalovirus

Phase 3

Data readout

Posoleucel Details
Virus-associated hemorrhagic cystitis , Adenovirus

Phase 3

Data readout

Posoleucel Details
BK virus, Kidney transplantation

Phase 2

Update

ALVR106 Details
Parainfluenza virus, Human metapneumovirus, Respiratory syncytial virus, Influenza

Phase 1/2

Interim update

Failed

Discontinued